Life Sciences
The company scored Class III Shonin clearance in Japan for its stroke platform and launched Rapid Edge Cloud, allowing continued AI access despite cloud connectivity.
The medtech company announced 40 innovations at RSNA23 aimed at streamlining the provider and patient healthcare experience.
The partnership will give St. Luke's Health System employees access to TytoCare's Home Smart Clinic and its plan members access to virtual visits with a $0 copay.
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.
The low-cost drug service will be part of Florida-based PharmcoRx's in-pharmacy offerings and will integrate into Expion Health's product suite.
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.
The company will use the funds to expand the reach of its sepsis-focused diagnostic test, IntelliSep.
The Boston-based company will allow employers to customize benefits packages to include adoption, assisted reproductive technologies and surrogacy options.
The Michigan-based cancer care center and medtech giant will create a framework to support scalable solutions that help advance precision medicine in the U.S.